These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7010290)

  • 21. Serum opsonic activity and peripheral neutrophil counts before and after exchange transfusion in infants with early onset group B streptococcal septicemia.
    Hall RT; Shigeoka AO; Hill HR
    Pediatr Infect Dis; 1983; 2(5):356-8. PubMed ID: 6356060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration.
    Evans JJ; Klesius PH; Shoemaker CA
    Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating and storage neutrophil changes in experimental type II group B streptococcal sepsis.
    Christensen RD; Shigeoka AO; Hill HR; Rothstein G
    Pediatr Res; 1980 Jun; 14(6):806-8. PubMed ID: 6995919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera.
    Fischer GW; Lowell GH; Crumrine MH; Bass JW
    J Exp Med; 1978 Sep; 148(3):776-86. PubMed ID: 29937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modified human immune serum globulin for intravenous administration: in vitro opsonic activity and in vivo protection against group B streptococcal disease in suckling rats.
    Fischer GW; Hunter KW; Wilson SR
    Acta Paediatr Scand; 1982 Jul; 71(4):639-44. PubMed ID: 6753478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phagocytosis of group B streptococcus by neutrophils from newborn infants.
    Harris MC; Stroobant J; Cody CS; Douglas SD; Polin RA
    Pediatr Res; 1983 May; 17(5):358-61. PubMed ID: 6343997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of specific antibody in neonatal bacterial infections: an overview.
    Anthony BF
    Pediatr Infect Dis; 1986; 5(3 Suppl):S164-7. PubMed ID: 3520499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.
    Schrag SJ; Zywicki S; Farley MM; Reingold AL; Harrison LH; Lefkowitz LB; Hadler JL; Danila R; Cieslak PR; Schuchat A
    N Engl J Med; 2000 Jan; 342(1):15-20. PubMed ID: 10620644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous interleukin-11 (IL-11) expression is increased and prophylactic use of exogenous IL-11 enhances platelet recovery and improves survival during thrombocytopenia associated with experimental group B streptococcal sepsis in neonatal rats.
    Chang M; Williams A; Ishizawa L; Knoppel A; van de Ven C; Cairo MS
    Blood Cells Mol Dis; 1996; 22(1):57-67. PubMed ID: 8807086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
    Pinto NM; Soskolne EI; Pearlman MD; Faix RG
    J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing group B streptococcal infection in newborns.
    Hueston WJ
    Am Fam Physician; 1991 Feb; 43(2):487-92. PubMed ID: 1990734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal infection: group B streptococcus.
    Hanley J
    Clin Evid; 2006 Jun; (15):476-9. PubMed ID: 16973020
    [No Abstract]   [Full Text] [Related]  

  • 33. Control of perinatal group B streptococcal sepsis: efficacy of single injection of aqueous penicillin at birth.
    Steigman AJ; Bottone EJ; Hanna BA
    Mt Sinai J Med; 1978; 45(6):685-93. PubMed ID: 368609
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci.
    Hill HR; Gonzales LA; Knappe WA; Fischer GW; Kelsey DK; Raff HV
    J Infect Dis; 1991 Apr; 163(4):792-8. PubMed ID: 2010632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraamniotic infection due to group G streptococcus: treatment and antibody response.
    Larsen JW; London WT; Baker CJ; Curfman BL; Sever JL
    Obstet Gynecol; 1981 Aug; 58(2):222-6. PubMed ID: 7019795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A history of neonatal group B streptococcus with its related morbidity and mortality rates in the United States.
    Dermer P; Lee C; Eggert J; Few B
    J Pediatr Nurs; 2004 Oct; 19(5):357-63. PubMed ID: 15614260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocytic stem cell (CFUc) proliferation in experimental group B streptococcal sepsis.
    Christensen RD; Hill HR; Rothstein G
    Pediatr Res; 1983 Apr; 17(4):278-80. PubMed ID: 6856389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic analysis of a human immunoglobulin M monoclonal antibody in neonatal Macaca fascicularis.
    Raff HV; Shuford W; Wolff E; Rubens CE
    Pediatr Res; 1991 Mar; 29(3):310-4. PubMed ID: 2034481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoprophylaxis and immunotherapy of neonatal group B streptococcal infections.
    Gotoff SP
    Infection; 1984; 12(2):151-6. PubMed ID: 6376366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin therapy for neonatal sepsis: an overview of animal and clinical studies.
    Fischer GW
    J Clin Immunol; 1990 Nov; 10(6 Suppl):40S-46S. PubMed ID: 2081788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.